Hemanext
Pre-clinicalDevelops technologies to improve the quality and shelf life of red blood cells for transfusion.
Founded
2011
Focus
HematologyBlood TransfusionMedical Devices
About
Develops technologies to improve the quality and shelf life of red blood cells for transfusion.
Funding History
3Total raised: $60M
Series C$20MDSM VenturingJun 15, 2021
Series B$25MDSM VenturingFeb 15, 2020
Series A$15MDSM VenturingJan 15, 2018
Company Info
TypePrivate
Founded2011
LocationLexington, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile